Immunic, Inc.
IMUX
$12.07
-$0.12-0.98%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -27.14% | -27.93% | 23.34% | -4.97% | -25.44% |
| Total Depreciation and Amortization | -20.93% | -23.26% | 20.00% | -4.76% | 38.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 257.78% | 120.38% | -16.93% | 85.04% | 25.34% |
| Change in Net Operating Assets | -1,933.64% | 582.30% | -970.83% | 11.92% | -92.22% |
| Cash from Operations | -25.96% | 20.55% | 16.03% | 3.15% | -44.43% |
| Capital Expenditure | -591.67% | 95.74% | -266.67% | -34.00% | 80.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -591.67% | 95.74% | -266.67% | -34.00% | 80.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -28.92% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.82% | -- | -23.38% | -- | -- |
| Foreign Exchange rate Adjustments | -402.26% | -142.05% | 19.07% | -86.70% | 133.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -176.89% | 901.10% | 16.04% | 2.18% | 332.80% |